NewslettersCell Therapy NewsSevere Hematotoxicity After CD19 CAR-T Therapy Is Associated with Suppressive Immune Dysregulation and Limited CAR-T ExpansionBy Jamie Kang - September 25, 20230108Scientists investigated how CAR T cell expansion dynamics and serum proteomics affected neutrophil recovery phenotypes after CD19-directed CAR T cell therapy.[Science Advances]Full Article